Literature DB >> 36271008

Development and cross-national investigation of a model explaining participation in WHO-recommended and placebo behaviours to prevent COVID-19 infection.

Joanna Kłosowska1, Elżbieta A Bajcar2, Helena Bieniek2, Justyna Brączyk2, Mohsen Joshanloo3, Katia Mattarozzi4, Arianna Bagnis4, Moa Pontén5, Maria Lalouni5, Andrew L Geers6, Kelly S Clemens6, Joonha Park7, Gahee Choi3, Yun-Kyeung Choi3, Wookyoung Jung3, Eunjung Son3, Hyae Young Yoon3, Przemysław Bąbel2.   

Abstract

To protect themselves from COVID-19, people follow the recommendations of the authorities, but they also resort to placebos. To stop the virus, it is important to understand the factors underlying both types of preventive behaviour. This study examined whether our model (developed based on the Health Belief Model and the Transactional Model of Stress) can explain participation in WHO-recommended and placebo actions during the pandemic. Model was tested on a sample of 3346 participants from Italy, Japan, Poland, Korea, Sweden, and the US. It was broadly supported: objective risk and cues to action showed both direct and indirect (through perceived threat) associations with preventive behaviours. Moreover, locus of control, decision balance, health anxiety and preventive coping moderated these relationships. Numerous differences were also found between countries. We conclude that beliefs about control over health and perceived benefits of actions are critical to the development of interventions to improve adherence to recommendations.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36271008     DOI: 10.1038/s41598-022-17303-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  37 in total

1.  Sustained behavior change is key to preventing and tackling future pandemics.

Authors:  Susan Michie; Robert West
Journal:  Nat Med       Date:  2021-05-10       Impact factor: 53.440

2.  Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries.

Authors:  Vincenzo Galasso; Vincent Pons; Paola Profeta; Michael Becher; Sylvain Brouard; Martial Foucault
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-15       Impact factor: 11.205

3.  Role of Threat and Coping Appraisal in Protection Motivation for Adoption of Preventive Behavior During COVID-19 Pandemic.

Authors:  Arista Lahiri; Sweety Suman Jha; Arup Chakraborty; Madhumita Dobe; Abhijit Dey
Journal:  Front Public Health       Date:  2021-07-05

4.  The use of placebo and non-specific therapies and their relation to basic professional attitudes and the use of complementary therapies among German physicians--a cross-sectional survey.

Authors:  Klaus Linde; Clara Friedrichs; Anna Alscher; Stefan Wagenpfeil; Karin Meissner; Antonius Schneider
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

5.  Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants.

Authors:  Laura M Kemppainen; Teemu T Kemppainen; Jutta A Reippainen; Suvi T Salmenniemi; Pia H Vuolanto
Journal:  Scand J Public Health       Date:  2017-10-04       Impact factor: 3.021

6.  How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know.

Authors:  Gordon J G Asmundson; Steven Taylor
Journal:  J Anxiety Disord       Date:  2020-03-10

7.  Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China.

Authors:  Benjamin F Maier; Dirk Brockmann
Journal:  Science       Date:  2020-04-08       Impact factor: 47.728

8.  European Headache Federation recommendations for placebo and nocebo terminology.

Authors:  Dimos D Mitsikostas; Charlotte Blease; Elisa Carlino; Luana Colloca; Andrew L Geers; Jeremy Howick; Andrea W M Evers; Magne A Flaten; John M Kelley; Irving Kirsch; Regine Klinger; Antoinette MaassenVanDenBrink; Daniel E Moerman; Petros P Sfikakis; Lene Vase; Tor D Wager; Fabrizio Benedetti
Journal:  J Headache Pain       Date:  2020-09-25       Impact factor: 7.277

9.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.